6.66
price up icon1.22%   0.08
after-market Dopo l'orario di chiusura: 6.64 -0.02 -0.30%
loading
Precedente Chiudi:
$6.58
Aprire:
$6.57
Volume 24 ore:
31,186
Relative Volume:
0.44
Capitalizzazione di mercato:
$154.80M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-7.50%
1M Prestazione:
-0.45%
6M Prestazione:
-27.61%
1 anno Prestazione:
-18.08%
Intervallo 1D:
Value
$6.50
$6.81
Intervallo di 1 settimana:
Value
$6.295
$7.34
Portata 52W:
Value
$5.47
$11.99

Actuate Therapeutics Inc Stock (ACTU) Company Profile

Name
Nome
Actuate Therapeutics Inc
Name
Telefono
847-986-4190
Name
Indirizzo
1751 RIVER RUN, FORT WORTH
Name
Dipendente
10
Name
Cinguettio
Name
Prossima data di guadagno
2025-09-03
Name
Ultimi documenti SEC
Name
ACTU's Discussions on Twitter

Confronta ACTU con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACTU
Actuate Therapeutics Inc
6.66 152.94M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-26 Iniziato B. Riley Securities Buy
2025-04-22 Iniziato Craig Hallum Buy
2025-03-17 Iniziato H.C. Wainwright Buy

Actuate Therapeutics Inc Borsa (ACTU) Ultime notizie

pulisher
Nov 02, 2025

Real time scanner hits for Actuate Therapeutics Inc. explainedGold Moves & Risk Managed Investment Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why Actuate Therapeutics Inc. stock could benefit from AI revolution2025 Market WrapUp & Safe Capital Preservation Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What’s next for Actuate Therapeutics Inc. stock priceEarnings Growth Report & Entry Point Strategy Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using R and stats models for Actuate Therapeutics Inc. forecastingEarnings Miss & Weekly Watchlist of Top Performers - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What makes Actuate Therapeutics Inc. stock attractive to growth fundsGlobal Markets & Free High Return Stock Watch Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

What indicators show strength in Actuate Therapeutics Inc.July 2025 Setups & Verified Momentum Stock Watchlist - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 09:18:34 - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Advanced analytics toolkit walkthrough for Actuate Therapeutics Inc.Earnings Summary Report & Weekly Stock Performance Updates - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is it time to cut losses on Actuate Therapeutics Inc.2025 Market Trends & Detailed Earnings Play Strategies - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

How Actuate Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 03:58:11 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Actuate Therapeutics Inc. building a consolidation baseExit Point & AI Driven Stock Movement Reports - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Actuate Therapeutics Inc. stock benefits from tech adoptionEarnings Recap Summary & Daily Stock Trend Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 29, 2025

Is Actuate Therapeutics Inc. stock gaining market shareStop Loss & Weekly Watchlist for Hot Stocks - Fundação Cultural do Pará

Oct 29, 2025
pulisher
Oct 28, 2025

Actuate Therapeutics shares sink on pricing of $15M public offering of common stock - MSN

Oct 28, 2025
pulisher
Oct 28, 2025

Is Actuate Therapeutics Inc. stock near bottom after decline2025 Major Catalysts & Stock Portfolio Risk Control - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

EMA gives OMPD to Actuate’s pancreatic cancer therapy - MSN

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 18:21:51 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Strategies to average down on Actuate Therapeutics Inc.Bond Market & Real-Time Stock Price Movement Reports - newser.com

Oct 27, 2025

Actuate Therapeutics Inc Azioni (ACTU) Dati Finanziari

Non sono disponibili dati finanziari per Actuate Therapeutics Inc (ACTU). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):